Leonhardt Ventures
  • Home
  • About
    • About us
    • 2021 Top Achievements
    • Leonhardt Ventures Portfolio Clinical Trials Listing
    • Founder Bio
    • Development Pipeline
    • Regenerative Medtech
    • Media
      • Company Logos
    • LV Team
      • Board of Directors
      • Team
      • Accelerator Core Team
      • Portfolio Startups Boards
      • Scientific Advisory Board
  • Our Startups
  • News
  • Investors
    • Invest in us
    • Agreements & Forms
      • Agreement Forms
      • Master Patent IP License and Development Agreement
      • Accelerator Membership Agreement
      • Term Sheet
      • 409a Valuation Accelerator
      • Simple Agreement for Future Equity
        • Simple Agreement for Future Equity – Word
        • Simple Agreement for Future Equity – PDF
    • Leonhardts Launchpads
      • Leonhardt’s Launchpads Valuations
      • Accelerator Business Model
      • Cap Tables and Valuations
    • Important
      • 2023 Budget
      • 2022 Budget
      • 2022 Compared YTD Budget
      • Legal Terms Summary
      • Executive Chairman’s 2022 Update
      • Executive Chairman’s Best guess estimate June 2022 on portfolio assets closest to exit
      • Board Governance
      • 2023 Goals
      • Current Clinical Trials
      • Executive Summary
    • Clinical Studies
      • Clinical Study Enrollment 10/1/19
    • Annual Reports
      • 2020-2023
        • 2023 Annual Report
        • Mid-Year 2022 Semi-Annual Report
        • 2022 Annual Report Executive Summary
        • 2021 Annual Report
        • 2020 Annual Report
      • 2016 – 2019
        • 2019 Annual Report
        • 2018 Annual Report
        • 2017 Annual Report
        • 2016 Annual Report
      • 2012-2015
        • 2015/16 Annual report
        • 1Q 2015 Newsletter
        • 2013/14 Annual Newsletter
        • 2012 Fall Newsletter
    • Investor FAQ
    • Leonhardt Ventures LLC Patent Licenses 2022
  • Contact
Select Page

SkinStim and HairCell Select NULASTIN® as Supplier of Elastin Based Serum/Creams for Combination Therapy Studies for Skin and Hair Regeneration

by hleonhardt | Sep 23, 2020 | News, Uncategorized

Irvine, CA and Boulder, CO – SkinStim and HairCell, two startups in the Leonhardt’s Launchpads innovation and startup accelerator(s), announced today a working partnership with NULASTIN®, an anti-aging skincare and haircare company. Leonhardt’s SkinStim...

Leonhardt’s Launchpads Executive Chairman & CEO Mid Year 2020 Stakeholder Update

by hleonhardt | Jul 23, 2020 | News, Uncategorized

Irvine, California, July 23rd, 2020 – Leonhardt’s Launchpads by Cal-X Stars Business Accelerator, Inc. is an innovation accelerator focused on organ regeneration and recovery based on a common IP platform of bioelectrics and biologics –...

Second Heart Assist Announces Successful Completion of Long-Duration Pre-Clinical Studies

by hleonhardt | Jul 23, 2020 | News, Uncategorized

First Long-Duration Clinical Studies in Cardio-Renal Syndrome Patients Now Scheduled to Take Place July 2020 in Tbilisi, Georgia NEWS PROVIDED BY Second Heart Assist, Inc. June 22nd, 2020 7:00am ET  Salt Lake City, Utah, June 22nd, 2020 /PRDistribution/ — Second...

CancerCell a Leonhardt’s Launchpads Startup Announces Filing of Patent Application for a Novel Bioelectric OPG Treatment Technology for Multiple Myeloma and Other Cancers

by hleonhardt | Jul 23, 2020 | News, Uncategorized

May Also by Useful in Treating Osteoporosis by startup OrthoStim  July 2nd, 2020 IRVINE, CALIFORNIA –(PR Distribution)- CancerCell www.cancercellinc.com, a biotechnology LTP stage startup within the Leonhardt’s Launchpads innovation and startup launch...

BladderCell Completes Landmark First-in-Human Clinical Study

by hleonhardt | Jul 23, 2020 | News, Uncategorized

Data show patients treated with BladderCell non-invasive bioelectric stimulation system improved urinary incontinence symptoms and quality of life. BladderCell is a medical technology platform within the Leonhardt’s Launchpads innovation and startup launch...
« Older Entries
Next Entries »

Recent Posts

  • Executive Chairman’s Best guess estimate June 2023 on portfolio assets closest to exit
  • 2023 Annual Shareholder Meeting.
  • Episode 138: Howard Leonhardt – The Future of Longevity & Wellness is Here!
  • 1Q 2023 Update Letter to Shareholders for accelerator and portfolio
  • BodStim Suits Up To Revolutionize Fitness And Shows Significant Promise For Enhancing Longevity
  • Facebook
  • X
© Copyright Leonhardt Ventures | Website by FizzPOP Media